XLON
CRW
Market cap509mUSD
Jul 09, Last price
1,110.00GBP
1D
-0.72%
1Q
-20.60%
Jan 2017
-16.23%
IPO
678.95%
Name
Craneware PLC
Chart & Performance
P/E
25.92
P/S
2.48
EPS
0.57
Div Yield, %
2.88%
Shrs. gr., 5y
5.53%
Rev. gr., 5y
23.53%
Revenues
206m
+8.66%
Net income
20m
+68.02%
CFO
60m
+43.08%
Dividend
Nov 27, 202518.5 GBP/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Craneware plc, alongside its various subsidiaries, is dedicated to developing, licensing, and providing ongoing support for specialized software solutions within the United States healthcare industry. The company's comprehensive suite of products addresses a wide range of operational and financial needs. For revenue cycle and financial management, Craneware offers Trisus pricing transparency software, designed to clarify pricing information, along with Trisus Pricing Analyzer to automate and simplify price modeling. Its Trisus Chargemaster provides automated management of chargemaster data, while InSight Audit assists government and commercial payors with audit processes. Additionally, InSight Denials facilitates the analysis, tracking, and reporting of claims denial data, and Trisus Claims Informatics offers retrospective analytical insights to identify charge capture risks. In the realm of clinical operations and supply chain, solutions include InSight Medical Necessity, which helps U.S. payors determine medical necessity; Trisus Supply, aimed at enhancing reimbursement for medical supplies; and Trisus Healthcare Intelligence, delivering patient-level insights into resource consumption. The portfolio also extends to Trisus Medication Analytic and Trisus Supplies Assistant solutions. Craneware also features a specialized line of pharmacy and drug tracking software. This includes Sentinel for drug tracking, Sentrex (a SaaS platform enabling covered entities to expand medication access), Sentrex 330, a Referral Verification System, and Sentry Core, which streamlines the complexities of pharmacy procurement, utilization, and compliance. Beyond its software offerings, Craneware provides professional and appeal services. The company was founded in 1999 and is headquartered in Edinburgh, United Kingdom.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑06 | 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||